Form 8-K - Current report:
SEC Accession No. 0001193125-19-142949
Filing Date
2019-05-09
Accepted
2019-05-09 16:01:57
Documents
3
Period of Report
2019-05-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d740290d8k.htm 8-K 23121
2 EX-3.1 d740290dex31.htm EX-3.1 47874
3 EX-3.2 d740290dex32.htm EX-3.2 128511
  Complete submission text file 0001193125-19-142949.txt   200668
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38886 | Film No.: 19810382
SIC: 2834 Pharmaceutical Preparations